SEARCH

SEARCH BY CITATION

References

  • 1
    Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352(22): 231424.
  • 2
    Dickel H, Kuss O, Schmidt A, Schmitt J, Diepgen TL. [Incidence of occupation-related skin diseases in skin-exposure occupational groups]. Hautarzt 2001; 52(7): 61523.
  • 3
    Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema – A population-based study. Br J Dermatol 2007; 158(2): 3519.
  • 4
    Schmitt J, Maywald U, Schmitt NM, Meurer M, Kirch W. Cardiovascular risk factors and psychiatric comorbidity in patients with atopic eczema. A population-based case-control study. 5th Georg Rajka International Symposium on Atopic Dermatitis Kyoto Abstract-book, 47. 2008; Ref Type: Abstract.
  • 5
    Schmitt J, Csotonyi F, Bauer A, Meurer M. Determinants of treatment goals and satisfaction of patients with atopic eczema. J Dtsch Dermatol Ges. 2008; 6(6): 45865.
  • 6
    Swart E, Ihle P. Routinedaten im Gesundheitswesen – Handbuch Sekun-därdatenanalyse: Grundlagen, Methoden und Perspektiven. 1. Auflage. Verlag Hans Huber, Bern , 2005.
  • 7
    Arbeitsgruppe Erhebung und Nutzung vonSekundärdaten (AGENS) der Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP). Gute Praxis Sekundärdatenanalyse (GPS). In: SwartE, IhleP: Routinedaten im Gesundheitswesen – Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven. Bern : Verlag Hans Huber, 2005: 40512.
  • 8
    Köster I, Von Ferber L. Interne Diagnosevalidierung. In: Von FerberL, BehrensJ: Public Health Forschung mit Gesundheits- und Sozialdaten. Stand und Perspektiven. Sankt Augustin : Asgard-Verlag, 1997: 5564.
  • 9
    Niedner R. [External administration of glucocorticosteroids. Part 1: Administration guidelines–classification]. Fortschr Med 1992; 110(17): 3279.
  • 10
    Hatz HJ. Glucocorticoide. Immunologische Grundlagen, Pharmakologie und Therapierichtlinien. 1. Auflage. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart , 1998.
  • 11
    Schmitt J, Schmitt NM, Kirch W, Meurer M. Bedeutung des atopischen Ekzems in der ambulanten medizinischen Versorgung. Eine Sekundärdatenanalyse. Hautarzt 2008; (submitted).
  • 12
    Horü KA, Simon SD, Liu DY, Sharma V. Atopic dermatitis in children in the United States, 1997–2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics 2007; 120(3): e52734.
  • 13
    Schmitt J, Schmitt NM, Meurer M. Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. JEADV 2007; 21: 60619.
  • 14
    Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007; 87(2): 10011.
  • 15
    Werfel T, Aberer W, Augustin M, Biedermann T, Fölster-Holst R, Friedrichts F. Neurodermitis (Leitlinie AMWF). Arbeitsgemeinschaft der wissenschaftlichen Medizinischen Fachge-sellschaften (AWMF) 2008; Nr. 013/027.
  • 16
    Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield L F, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148 Suppl 63: 310.
  • 17
    Schmitt J, Meurer M, Schwanebeck U, Grählert X, Schäkel K. Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. A randomised controlled trial. Dermatology. 2008; 217(4): 299308.
  • 18
    Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008; 63(6): 74250.
  • 19
    Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002; 147(3): 52837.
  • 20
    Peserico A, Stadtler G, Sebastian M, Fernandez RS, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008; 158(4): 8017.
  • 21
    Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326(7403): 1367.
  • 22
    Virtanen H, Remitz A, Malmberg P, Rytila P, Metso T, Haahtela T, Reitamo S. Topical tacrolimus in the treatment of atopic dermatitis – does it benefit the airways? A 4-year open follow-up. J Allergy Clin Immunol 2007; 120(6): 14646.